1. Home
  2. RCKT vs TACO Comparison

RCKT vs TACO Comparison

Compare RCKT & TACO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • TACO
  • Stock Information
  • Founded
  • RCKT 1999
  • TACO 2024
  • Country
  • RCKT United States
  • TACO United States
  • Employees
  • RCKT N/A
  • TACO N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • TACO Blank Checks
  • Sector
  • RCKT Health Care
  • TACO Finance
  • Exchange
  • RCKT Nasdaq
  • TACO Nasdaq
  • Market Cap
  • RCKT 340.9M
  • TACO 393.9M
  • IPO Year
  • RCKT N/A
  • TACO 2025
  • Fundamental
  • Price
  • RCKT $3.03
  • TACO $10.18
  • Analyst Decision
  • RCKT Buy
  • TACO
  • Analyst Count
  • RCKT 13
  • TACO 0
  • Target Price
  • RCKT $12.88
  • TACO N/A
  • AVG Volume (30 Days)
  • RCKT 1.9M
  • TACO 496.4K
  • Earning Date
  • RCKT 11-06-2025
  • TACO 01-01-0001
  • Dividend Yield
  • RCKT N/A
  • TACO N/A
  • EPS Growth
  • RCKT N/A
  • TACO N/A
  • EPS
  • RCKT N/A
  • TACO N/A
  • Revenue
  • RCKT N/A
  • TACO N/A
  • Revenue This Year
  • RCKT N/A
  • TACO N/A
  • Revenue Next Year
  • RCKT $3,582.16
  • TACO N/A
  • P/E Ratio
  • RCKT N/A
  • TACO N/A
  • Revenue Growth
  • RCKT N/A
  • TACO N/A
  • 52 Week Low
  • RCKT $2.19
  • TACO $10.16
  • 52 Week High
  • RCKT $15.01
  • TACO $11.32
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 37.29
  • TACO N/A
  • Support Level
  • RCKT $3.10
  • TACO N/A
  • Resistance Level
  • RCKT $3.37
  • TACO N/A
  • Average True Range (ATR)
  • RCKT 0.20
  • TACO 0.00
  • MACD
  • RCKT -0.07
  • TACO 0.00
  • Stochastic Oscillator
  • RCKT 7.73
  • TACO 0.00

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About TACO Berto Acquisition Corp. Ordinary Shares

Berto Acquisition Corp is a blank check company.

Share on Social Networks: